What is the official website of BioLife Plasma Services ?

The official website of BioLife Plasma Services is http://www.biolifeplasma.com.

What is BioLife Plasma Services's cybersecurity risk score?

BioLife Plasma Services has an AI-generated cybersecurity risk score of 719 out of 1000, indicating a Moderate security posture according to Rankiteo's assessment.

How many security incidents has BioLife Plasma Services experienced?

According to Rankiteo, BioLife Plasma Services currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has BioLife Plasma Services been affected by any supply chain cyber incidents ?

According to Rankiteo, BioLife Plasma Services has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does BioLife Plasma Services have SOC 2 Type 1 certification ?

According to Rankiteo, BioLife Plasma Services is not certified under SOC 2 Type 1.

Does BioLife Plasma Services have SOC 2 Type 2 certification ?

According to Rankiteo, BioLife Plasma Services does not hold a SOC 2 Type 2 certification.

Does BioLife Plasma Services comply with GDPR ?

According to Rankiteo, BioLife Plasma Services is not listed as GDPR compliant.

Does BioLife Plasma Services have PCI DSS certification ?

According to Rankiteo, BioLife Plasma Services does not currently maintain PCI DSS compliance.

Does BioLife Plasma Services comply with HIPAA ?

According to Rankiteo, BioLife Plasma Services is not compliant with HIPAA regulations.

Does BioLife Plasma Services have ISO 27001 certification ?

According to Rankiteo,BioLife Plasma Services is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does BioLife Plasma Services operate in ?

BioLife Plasma Services operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does BioLife Plasma Services have ?

BioLife Plasma Services employs approximately 3,849 people worldwide.

Does BioLife Plasma Services own any subsidiaries ?

BioLife Plasma Services presently has no subsidiaries across any sectors.

How many LinkedIn followers does BioLife Plasma Services have ?

BioLife Plasma Services's official LinkedIn profile has approximately 22,354 followers.

What is the NAICS classification code for BioLife Plasma Services ?

BioLife Plasma Services is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does BioLife Plasma Services have a Crunchbase profile ?

No, BioLife Plasma Services does not have a profile on Crunchbase.

Does BioLife Plasma Services have a LinkedIn profile ?

Yes, BioLife Plasma Services maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/biolifeplasmaservices.

How many cybersecurity incidents has BioLife Plasma Services experienced ?

As of September 21, 2026, Rankiteo reports that BioLife Plasma Services has experienced 1 cybersecurity incidents.

How many peer or competitor companies does BioLife Plasma Services have ?

BioLife Plasma Services has an estimated 5,768 peer or competitor companies worldwide.

What types of cybersecurity incidents has BioLife Plasma Services faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

BPS

Boost Score +25 with badge (5 left)

719

/1000

Moderate

744

/1000

Moderate

BioLife Plasma Services Vendor Cyber Rating & Cyber Score

biolifeplasma.com

Add Your Compliance Badge

Every day at BioLife, we feel good knowing that what we do helps improve the lives of patients with rare diseases. While you focus on our donors, we’ll support you. We offer a purpose you can believe in, a team you can count on, opportunities for career growth, and a comprehensive benefits program, all in a fast-paced, friendly environment.

BPS

BioLife Plasma Services CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

BioLife Plasma Serv...

Breach

1/2024

BIO201072825

Loading…

A.I.

BPS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for BPS

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for BioLife Plasma Services in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for BioLife Plasma Services in 2026.

Incident Types BPS vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for BioLife Plasma Services in 2026.

Incident History - BPS (X = Date, Y = Severity)

Loading…

SUBSIDIARY

BioLife Plasma Services Subsidiaries

Parent Company

BPS

Pharmaceutical Manufacturing

Website: http://www.biolifeplasma.com

Company Size: 5,001-10,000 employees

No subsidiary data available for this company.

Loading…

BioLife Plasma Services Similar Companies

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

Johnson & Johnson Innovative Medicine

jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Loading…

NEWS

BioLife Plasma Services CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

May 05, 2025 07:00 AM

BioLife Plasma Services Introduces the New Fresenius Kabi Adaptive Nomogram Across its U.S. Network of Plasma Donation Centers

BANNOCKBURN, Ill., May 05, 2025--BioLife Plasma Services, part of Takeda (TSE:4502/NYSE:TAK), today announced that it has begun introducing...

Read Article

January 23, 2025 08:00 AM

BioLife Plasma Sued Over Data Sharing With Snap, Salesforce

BioLife Plasma Services LP and Takeda Pharmaceuticals USA Inc. enabled third parties to intercept the personal information of BioLife...

Read Article

March 21, 2024 07:00 AM

BioLife Plasma Services Data Breach Class Action Lawsuit Assistance

If you were affected by the recent BioLife Plasma Services data breach, our data breach lawyers can help you learn your legal options.

Read Article

August 19, 2021 07:00 AM

BioLife Plasma Services Opens First All-Electric Plasma Donation Center

The new Tukwila, WA center underscores the urgent patient need for plasma while supporting Takeda's sustainability goal to have zero carbon...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-94094

SUMMARY

A flaw has been found in OpenClaw up to 2026.9.5. Affected is the function createCanvasHostHandler of the file extensions/canvas/src/host/server.ts of the component Canvas Host Route. Executing a manipulation can lead to denial of service. The attack can be launched remotely. The exploit has been published and may be used. Fix suggestion's "streaming/size-limit" was never shipped - latest 2026.9.5 still buffers the whole file via readFile() (src/canvas/serve.runtime.ts:17,114), unlike the sibling WS path which caps at 64KB. The vendor was contacted early about this disclosure.

Published

Date2026-09-20

Updated

Date2026-09-20

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:N/I:N/A:P

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-94093

SUMMARY

A security vulnerability has been detected in DLR-RM stable-baselines3 up to 2.9.0. This affects the function PPO.load/load_replay_buffer/VecNormalize.load of the file save_util.py. Such manipulation leads to deserialization. It is possible to launch the attack remotely. The exploit has been disclosed publicly and may be used. In v2.9.0 the PyTorch tensor load path is hardened (weights_only=True), but that hardening was later reverted on master via PR #1913 "Hotfix: revert loading with weights_only=True" [blocked] to fix PyTorch 1.13 compat - so even the one "safe" path is inconsistent across versions. #2281 was closed as a duplicate of #1831 since both are unsafe pickle deserialization - but #1831's fix (PR #41) only gated the Hugging Face Hub loader in the separate huggingface_sb3 package. This finding covers the core stable_baselines3 load APIs (PPO.load, load_replay_buffer, VecNormalize.load), which have no safe mode or gate and remained exploitable in v2.9.0 until the outstanding hardening (PR #2264) ships.

Published

Date2026-09-20

Updated

Date2026-09-20

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-94092

SUMMARY

A vulnerability was detected in dmlc dgl up to 2.1.0. This impacts the function load_info/_read_torch_data of the file utils.py. Performing a manipulation of the argument path results in deserialization. The attack can be initiated remotely. The exploit is now public and may be used. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-09-20

Updated

Date2026-09-20

RISK INFORMATION (Score: 5.5)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.1

REFERENCES

CVE-2026-94091

SUMMARY

A weakness has been identified in piskvorky gensim up to 4.4.0. The impacted element is the function Load of the file gensim/utils.py of the component Model Loader. This manipulation of the argument fname causes deserialization. It is possible to initiate the attack remotely. The exploit has been made available to the public and could be used for attacks. Maintainer closed #3663 same-day with no comment, PR, or fix; repo's last push (2025-11-01) predates the report, so the unsafe pickle.load in SaveLoad.load remains unguarded at develop HEAD.

Published

Date2026-09-20

Updated

Date2026-09-20

RISK INFORMATION (Score: 5.5)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.1

REFERENCES

CVE-2026-94090

SUMMARY

A security flaw has been discovered in JusticeRage Manalyze 1.0.0. The affected element is the function PE::_parse_debug of the file manape/pe.cpp of the component PE Parser. The manipulation of the argument misc.Length results in integer underflow. The attack may be performed from remote. The patch is identified as 3e299685759f4f767088871de58c5d07f98ee382. A patch should be applied to remediate this issue.

Published

Date2026-09-20

Updated

Date2026-09-20

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

BioLife Plasma Services Vendor Cyber Rating & Cyber Score

BPS A.I CyberSecurity Scoring

BioLife Plasma Services CyberSecurity News & History

BPS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for BPS

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types BPS vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - BPS (X = Date, Y = Severity)

BioLife Plasma Services Subsidiaries

Parent Company

BPS

BioLife Plasma Services Similar Companies

Sanofi

Novartis

Zoetis

Johnson & Johnson Innovative Medicine

MANKIND PHARMA LTD

AUROBINDO PHARMA LTD

Ipca Laboratories Limited

Lupin

Takeda

BioLife Plasma Services CyberSecurity News

BioLife Plasma Services Introduces the New Fresenius Kabi Adaptive Nomogram Across its U.S. Network of Plasma Donation Centers

BioLife Plasma Sued Over Data Sharing With Snap, Salesforce

BioLife Plasma Services Data Breach Class Action Lawsuit Assistance

BioLife Plasma Services Opens First All-Electric Plasma Donation Center

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

BioLife Plasma Services CyberSecurity News & History

BPS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for BPS

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types BPS vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - BPS (X = Date, Y = Severity)

BioLife Plasma Services Subsidiaries

Parent Company

BPS

BioLife Plasma Services Similar Companies

Sanofi

Novartis

Zoetis

Johnson & Johnson Innovative Medicine

MANKIND PHARMA LTD

AUROBINDO PHARMA LTD

Ipca Laboratories Limited

Lupin

Takeda

BioLife Plasma Services CyberSecurity News

BioLife Plasma Services Introduces the New Fresenius Kabi Adaptive Nomogram Across its U.S. Network of Plasma Donation Centers

BioLife Plasma Sued Over Data Sharing With Snap, Salesforce

BioLife Plasma Services Data Breach Class Action Lawsuit Assistance

BioLife Plasma Services Opens First All-Electric Plasma Donation Center

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo